Clinical Trial Update: Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating pegylated interferon alfa-2a (Pegasys) in Korean adults with chronic hepatitis B; the current status of the study is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN